Skip to main content
Acta Crystallographica Section F: Structural Biology Communications logoLink to Acta Crystallographica Section F: Structural Biology Communications
. 2015 May 22;71(Pt 6):752–757. doi: 10.1107/S2053230X15007566

Structure of the catalytic domain of Mre11 from Chaetomium thermophilum

Florian Ulrich Seifert a, Katja Lammens a, Karl-Peter Hopfner a,*
PMCID: PMC4461342  PMID: 26057807

The crystal structure of the Mre11 nuclease dimer from the thermophilic eukaryote C. thermophilum is reported. Crystals of C. thermophilum Mre11, which plays an important role in DNA double-strand break repair, diffracted to 2.8 Å resolution and the structure was solved by the molecular-replacement technique.

Keywords: Mre11 nuclease, MRN complex

Abstract

Together with the Rad50 ATPase, the Mre11 nuclease forms an evolutionarily conserved protein complex that plays a central role in the repair of DNA double-strand breaks (DSBs). Mre11–Rad50 detects and processes DNA ends, and has functions in the tethering as well as the signalling of DSBs. The Mre11 dimer can bind one or two DNA ends or hairpins, and processes DNA endonucleolytically as well as exonucleolytically in the 3′-to-5′ direction. Here, the crystal structure of the Mre11 catalytic domain dimer from Chaetomium thermophilum (CtMre11CD) is reported. CtMre11CD crystals diffracted to 2.8 Å resolution and revealed previously undefined features within the dimer interface, in particular fully ordered eukaryote-specific insertion loops that considerably expand the dimer interface. Furthermore, comparison with other eukaryotic Mre11 structures reveals differences in the conformations of the dimer and the capping domain. In summary, the results reported here provide new insights into the architecture of the eukaryotic Mre11 dimer.

1. Introduction  

Double-strand breaks (DSBs), which occur through exposure to genotoxic chemicals, ionizing radiation or reactive oxygen species or during replication-fork blockage (Costanzo et al., 2001; Sutherland et al., 2000; Aguilera & Gómez-González, 2008; Cadet et al., 2012; Mehta & Haber, 2014), are one of the most threatening forms of DNA damage. On the other hand, DSBs are enzymatically introduced in a programmed fashion during meiosis and V(D)J or class-switch recombination during immunoglobulin development (Lam & Keeney, 2014; Gapud & Sleckman, 2011; Xu et al., 2012). To prevent chromosomal rearrangements and genome instability, organisms in all kingdoms of life have developed different DSB-repair pathways (Hanahan & Weinberg, 2011; Myung, Chen et al., 2001; Myung, Datta et al., 2001).

DSBs are repaired by principal pathways such as non­homologous end joining (NHEJ) and homology-directed repair or homologous recombination (HR), or alternative pathways such as microhomology-mediated end joining (MMEJ) (Chiruvella et al., 2013; Chapman et al., 2012). In eukaryotes, the Mre11–Rad50–Nbs1 (MRN) complex plays a key role in the early steps of DSB repair, and its function in the initial detection and processing of DNA ends is important for the choice between resection-dependent (HR, MMEJ) and resection-independent (NHEJ) pathways (Lisby et al., 2004; Truong et al., 2013; Chiruvella et al., 2013; Shibata et al., 2014). MRN consists of a dimer of Mre11, two Rad50s and, in eukaryotes, Nbs1 (Lammens et al., 2011; Schiller et al., 2012; Möckel et al., 2012; Lim et al., 2011; Arthur et al., 2004; Das et al., 2010; Limbo et al., 2012). The Mre11 nuclease forms the enzymatically active centre of the complex. In vitro, Mre11 is able to process DNA exonucleolytically in the 3′-to-5′ direction and cuts ssDNA endonucleolytically (Trujillo et al., 1998; Hopfner et al., 2001). To date, Mre11 has been found as a dimer in all available crystal structures. Although comparison of these structures reveals a highly conserved overall shape of the protein, consisting of an N-terminal phosphodiesterase domain followed by a capping domain, the dimer angle between the Mre11 protomers can adopt remarkably different conformations (Schiller et al., 2014). In eukaryotes, the dimer angle is stabilized by latching loops that provide a critical interaction site for Nbs1 with Mre11 (Schiller et al., 2012; Park et al., 2011). However, a substantial portion of the functionally important, eukaryote-specific latching loops remained disordered in previously determined structures (Schiller et al., 2012; Park et al., 2011). Here, we present the crystal structure of the Mre11 catalytic domain dimer from the thermophilic eukaryote Chaetomium thermophilum (CtMre11CD) at 2.8 Å resolution. We find interpretable electron density for the entire latching loops, revealing an unexpected expansion of the Mre11 dimer interface by this functionally critical region.

2. Materials and methods  

2.1. Protein expression and purification  

For co-expression, open reading frames for the components of the MRN head complex (MRNHC) were cloned into two different expression vectors. The Mre11 sequence coding for amino acids 1–537 was cloned into pET-21b vector (Novagen) with NdeI and NotI, and a C-terminal His6 tag from the vector was fused to the polypeptide chain. Three constructs coding for the Rad50 N- and C-termini (amino acids 1–224 and 1103–1315, respectively) as well as Nbs1 (amino acids 565–714) were first cloned into a modified polycistronic pET-29 vector with NdeI/NotI and then combined with AarI/AscI into a single vector. After co-transformation and induction at an OD600 of 0.8 with IPTG (0.3 mM final concentration), expression in Escherichia coli Rosetta (DE3) cells took place overnight at 18° C. After cell resuspension in lysis buffer (300 mM NaCl, 25 mM Tris pH 8.0) plus 10 mM imidazole and disruption by sonication, cell debris was removed by centrifugation. The supernatant was incubated with nickel–NTA (Qiagen) for 2 h at 7°C. The nickel–NTA column was washed with 10 column volumes (CVs) of lysis buffer and 5 CVs each of lysis buffer containing 20 and then 50 mM imidazole. The protein complex was eluted with lysis buffer containing 250 mM imidazole. Subsequently, size-exclusion chromatography (Superdex 200 26/60, GE Healthcare) was performed (buffer: 200 mM NaCl, 25 mM Tris pH 8.0); the purified protein was concentrated to 7.0 mg ml−1 and aliquots were frozen in liquid nitrogen.

2.2. Crystallization  

Crystallization trials with the MRNHC protein were performed by hanging-drop vapour diffusion (Table 1). Small plate-shaped crystals appeared after three months, and after a further month these were transferred into reservoir solution containing 10%(v/v) 2,3-butanediol for cryoprotection. The crystals were flash-cooled and stored in liquid nitrogen.

Table 1. Crystallization.

Method Hanging-drop vapour diffusion
Plate type 24-well plates (Crystalgen SuperClear Plates, pregreased; Jena Bioscience)
Temperature (K) 292
Protein concentration (mgml1) 7.0
Buffer composition of protein solution 200mM NaCl, 25mM Tris pH 8.0
Composition of reservoir solution 200mM ammonium citrate tribasic pH 6.87.0, 18%(w/v) PEG 3350
Volume and ratio of drop 3l; 2:1 protein:reservoir
Volume of reservoir (l) 500

2.3. Data collection and processing  

Data were collected on the X06SA beamline at the Swiss Light Source (SLS), Villigen, Switzerland. The data were indexed and integrated with XDS (Kabsch, 2010a ,b ). Data-collection statistics are shown in Table 2.

Table 2. Data collection and processing.

Values in parentheses are for the outer shell.

Diffraction source Beamline X06SA, SLS
Wavelength () 0.979600
Temperature (K) 199.4
Detector MAR Mosaic 225 CCD
Crystal-to-detector distance (mm) 270.00
Rotation range per image () 1.0
Total rotation range () 180
Exposure time per image (s) 1.0
Space group P212121
a, b, c () 56.7, 56.6, 304.6
, , () 90, 90, 90
Mosaicity () 0.245
Resolution range () 50.002.78 (2.952.78)
Total No. of reflections 168505 (22412)
No. of unique reflections 25153 (3657)
Completeness (%) 98.1 (89.5)
Multiplicity 6.7 (6.13)
I/(I) 11.18 (1.81)
CC1/2 99.6 (74.5)
R meas 0.136 (0.962)
Overall B factor from Wilson plot (2) 65.1

2.4. Structure solution and refinement  

The L-test from POINTLESS indicated the presence of twinning and further analysis with phenix.xtriage identified the twin operator as k, h, −l (Adams et al., 2010; Winn et al., 2011; Evans, 2006, 2011). The structure of the C. thermophilum Mre11 catalytic domain (CtMre11CD; amino acids 4–412) was solved by molecular replacement with Phaser (McCoy et al., 2007). The search model was the structure of monomeric Schizosaccharomyces pombe Mre11 (PDB entry 4fbq; Schiller et al., 2012), which was co-crystallized with an Nbs1 construct. The structure was refined with PHENIX, accounting for twinning (Adams et al., 2010), in combination with manual model building using Coot (Emsley & Cowtan, 2004; Emsley et al., 2010). An initial round of rigid-body refinement was followed by restrained refinement with TLS refinement. The F oF c map revealed density for two manganese ions in the active site, and water molecules were added manually. Structure factors and atomic coordinates of CtMre11CD have been deposited in the Protein Data Bank with accession code 4yke and refinement statistics are reported in Table 3.

Table 3. Structure refinement.

Values in parentheses are for the outer shell.

Resolution range () 49.522.78 (2.892.78)
Completeness (%) 98.2
No. of reflections, working set 25153 (2253)
No. of reflections, test set 1251 (110)
Final R work (%) 19.8 (30.8)
Final R free (%) 23.1 (40.1)
No. of non-H atoms
Protein 6548
Manganese 4
Water 60
Total 6612
R.m.s. deviations
Bonds () 0.003
Angles () 0.683
Average B factors (2)
Protein 83.9
Manganese 60.0
Water 45.0
Ramachandran plot
Favoured regions (%) 96
Additionally allowed (%) 4
Outliers (%) 0

3. Results and discussion  

We crystallized the catalytic domain of CtMre11 (CtMre11CD; amino acids 4–412) and determined the structure by molecular replacement using S. pombe Mre11 (SpMre11CD) as the search model (PDB entry 4fbq; Schiller et al., 2012). The crystallization screen contained the MRN head complex (MRNHC) and, presumably owing to proteolysis, CtMre11CD crystals formed. CtMre11CD contains an N-terminal nuclease domain, which is characterized by a phosphodiesterase motif, and a C-terminal capping domain (amino acids 300–412; Fig. 1 a). The asymmetric unit consists of two Mre11 protomers that together form the characteristic, previously observed Mre11 dimer mediated by interactions between α-helices α2 and α3 (Hopfner et al., 2001; Schiller et al., 2012; Fig. 1 and Supplementary Fig. S1). The interface between these two helices consists of mainly hydrophobic residues: Tyr70, Met73, Leu139 and Val142. The dimer interface is extended by Arg66, which forms hydrogen bonds to Asn62, Ser129 and Leu134 from the other protomer (Fig. 2 a). The two manganese ions that are present in the nuclease domains of both CtMre11CD protomers are coordinated in a similar fashion by the absolutely conserved residues Asp17, His19, Asp57, Asn124, His213, His241 and His243 (Schiller et al., 2012; Fig. 2 b).

Figure 1.

Figure 1

Crystal structure of CtMre11CD and comparison with Nbs1-bound and unbound SpMre11CD structures (SpMre11CD and SpMre11CD–Nbs1, respectively). (a) Structures of the dimer of the catalytic domains of SpMre11CD, CtMre11CD and SpMre11CD in complex with the Nbs1 peptide (purple; SpMre11CD–Nbs1; PDB entries 4fcx, 4yke and 4fbw, respectively). The models are displayed in ribbon representation. Mre11 protomers are highlighted in light and deep blue. (b) Details of the Mre11 dimer interface and the eukaryotic insertion loops (lime and brown). The conformation of the CtMre11CD insertion loops is similar to the conformation of the loops in the SpMre11CD–Nbs1 structure.

Figure 2.

Figure 2

Details of the Mre11CD crystal structure from C. thermophilum. (a) Detailed view of the CtMre11CD dimer interface consisting of α-helices α2 and α3 from each protomer. (b) CtMre11CD nuclease active site with two coordinated manganese ions (cyan). (c) Overlay of SpMre11CD (grey), SpMre11CD–Nbs1 (light blue) and CtMre11CD (deep blue) by alignment of the nuclease domains onto the nuclease domain of CtMre11CD indicates the movement of the capping domain by up to 5 Å. (d) Fully modelled eukaryotic insertion loop (lime and brown). The interaction between Arg77 and Phe102 is highlighted. Selected residues are depicted as colour-coded sticks and annotated. Hydrogen bonds in (a) and (d) are highlighted as dashed lines.

Structural comparison of the individual Mre11 protomers of CtMre11CD with Homo sapiens Mre11CD (HsMre11CD) and SpMre11CD reveals that they have similar structures, consistent with their high sequence identities of 46 and 61%, respectively (Schiller et al., 2012; Park et al., 2011; Sievers et al., 2011; Goujon et al., 2010). CtMre11CD largely adopts the conformation of SpMre11CD, but is even more compact than either Nbs1-bound or unbound SpMre11CD owing to an approximately 5 Å movement of the capping domain towards the nuclease active site (Fig. 2 c). In contrast, the conformation of the Mre11CD dimer displays greater variation between the eukaryotic Mre11 structures. CtMre11CD and SpMre11CD adopt similar conformations yet differ with respect to the human Mre11CD dimer, in which a significantly different interface between the two nuclease domains is stabilized by a disulfide bond. This disulfide bond is absent in the S. pombe structures and the presented CtMre11 structure (Park et al., 2011; Schiller et al., 2012).

Interestingly, comparison with SpMre11CD and the SpMre11CD–Nbs1 complex reveals that CtMre11CD has fully ordered insertion loops even in the absence of Nbs1, and we are now able to model the entire eukaryote-specific loop insertion that plays a critical role in the interaction with Nbs1 and in damage signalling (Figs. 1 and 2 d). In the case of SpMre11CD, Nbs1 binding partially orders the insertion loops, resulting in a more compact Mre11 dimer (Schiller et al., 2012; Fig. 1 b). Indeed, the dimeric conformation of CtMre11CD with fully ordered insertion loops is very similar to that of SpMre11CD bound to Nbs1, but is quite distinct from the more open SpMre11CD dimer conformation in the absence of Nbs1 (Fig. 3). The Nbs1-binding site bridging the SpMre11 dimer is occupied in the presented structure by symmetry-related molecules that may stabilize the insertion loops. This dimeric structure of Mre11 enables each nuclease active site to bind a dsDNA substrate and thus allows the bridging of two DNA ends (Williams et al., 2008). Interestingly, the insertion loops extend the Mre11 dimer interface through reaching across the lateral CtMre11CD dimer interface. Notably, the conserved phenylalanine (Phe102 in C. thermophilum) stacks with and stabilizes Arg77, a critical residue in stabilizing the Mre11 dimer interface (Schiller et al., 2012), of the opposing protomer (Fig. 2 d). As a result, the 1490 Å2 Mre11–Mre11 interface of CtMre11CD is twice as large as that of Mre11 from the thermophilic archaeon Pyrococcus furiosus (Krissinel & Henrick, 2007), in which the insertion loops are absent.

Figure 3.

Figure 3

Overlay of CtMre11CD, SpMre11CD and SpMre11CD–Nbs1. Structures of SpMre11CD (grey) and SpMre11CD–Nbs1 (light blue) dimers are aligned via one of the two CtMre11CD (dark blue) protomers to show the variability of the dimer interface and dimer angle. The distance between the capping domains of CtMre11CD and SpMre11CD reaches 28 Å.

In summary, this structure of CtMre11CD fully defines the eukaryotic insertion loops and shows that these loops expand the Mre11 dimer interface (Hopfner et al., 2001). Furthermore, our results show considerable flexibility not only between the Mre11 protomers but also between the phosphodiesterase domain and the capping domain.

Supplementary Material

PDB reference: Mre11 catalytic domain, 4yke

Figure S1 Elution profile of CtMre11CD and gel filtration standard (Bio-Rad) on analytical size exclusion chromatography column (S200 increase 5/150 GL). CtMre11CD (red) compared to gel filtration standard (blue): 1st peak (670 kDa), 2nd peak (158 kDa), 3rd peak (44 kDa), 4th peak (17 kDa), 5th peak (1.35 kDa). The catalytic domain of CtMre11 elutes at approximately the volume of a globular protein with a molecular weight of 158 kDa. These data show that Mre11 forms a defined multimer, given its non-globular shape presumably a dimer.. DOI: 10.1107/S2053230X15007566/no5082sup1.tif

Acknowledgments

We thank Brigitte Kessler for help with cloning and protein purification and Robert Byrne for comments on the manuscript, as well as the staff of the Swiss Light Source, Villigen, Switzerland for technical support. This work was funded by the German Research Council projects GRK1721 and SFB684, the Center for Integrated Protein Sciences Munich and the European Research Council Advanced Grant ATMMACHINE to K-PH.

References

  1. Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.
  2. Aguilera, A. & Gómez-González, B. (2008). Nature Rev. Genet. 9, 204–217. [DOI] [PubMed]
  3. Arthur, L. M., Gustausson, K., Hopfner, K.-P., Carson, C. T., Stracker, T. H., Karcher, A., Felton, D., Weitzman, M. D., Tainer, J. & Carney, J. P. (2004). Nucleic Acids Res. 32, 1886–1893. [DOI] [PMC free article] [PubMed]
  4. Cadet, J., Ravanat, J. L., TavernaPorro, M., Menoni, H. & Angelov, D. (2012). Cancer Lett. 327, 5–15. [DOI] [PubMed]
  5. Chapman, J. R., Taylor, M. R. G. & Boulton, S. J. (2012). Mol. Cell, 47, 497–510. [DOI] [PubMed]
  6. Chiruvella, K. K., Liang, Z. & Wilson, T. E. (2013). Cold Spring Harb. Perspect. Biol. 5, a012757. [DOI] [PMC free article] [PubMed]
  7. Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D. & Gautier, J. (2001). Mol. Cell, 8, 137–147. [DOI] [PubMed]
  8. Das, D. et al. (2010). J. Mol. Biol. 397, 647–663. [DOI] [PMC free article] [PubMed]
  9. Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. [DOI] [PubMed]
  10. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. [DOI] [PMC free article] [PubMed]
  11. Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
  12. Evans, P. R. (2011). Acta Cryst. D67, 282–292. [DOI] [PMC free article] [PubMed]
  13. Gapud, E. J. & Sleckman, B. P. (2011). Cell Cycle, 10, 1928–1935. [DOI] [PMC free article] [PubMed]
  14. Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J. & Lopez, R. (2010). Nucleic Acids Res. 38, W695–W699. [DOI] [PMC free article] [PubMed]
  15. Hanahan, D. & Weinberg, R. A. (2011). Cell, 144, 646–674. [DOI] [PubMed]
  16. Hopfner, K. P., Karcher, A., Craig, L., Woo, T. T., Carney, J. P. & Tainer, J. A. (2001). Cell, 105, 473–485. [DOI] [PubMed]
  17. Kabsch, W. (2010a). Acta Cryst. D66, 125–132. [DOI] [PMC free article] [PubMed]
  18. Kabsch, W. (2010b). Acta Cryst. D66, 133–144. [DOI] [PMC free article] [PubMed]
  19. Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. [DOI] [PubMed]
  20. Lam, I. & Keeney, S. (2014). Cold Spring Harb. Perspect. Biol. 7, a016634. [DOI] [PMC free article] [PubMed]
  21. Lammens, K., Bemeleit, D. J., Möckel, C., Clausing, E., Schele, A., Hartung, S., Schiller, C. B., Lucas, M., Angermüller, C., Söding, J., Strässer, K. & Hopfner, K. P. (2011). Cell, 145, 54–66. [DOI] [PMC free article] [PubMed]
  22. Lim, H. S., Kim, J. S., Park, Y. B., Gwon, G. H. & Cho, Y. (2011). Genes Dev. 25, 1091–1104. [DOI] [PMC free article] [PubMed]
  23. Limbo, O., Moiani, D., Kertokalio, A., Wyman, C., Tainer, J. A. & Russell, P. (2012). Nucleic Acids Res. 40, 11435–11449. [DOI] [PMC free article] [PubMed]
  24. Lisby, M., Barlow, J. H., Burgess, R. C. & Rothstein, R. (2004). Cell, 118, 699–713. [DOI] [PubMed]
  25. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. [DOI] [PMC free article] [PubMed]
  26. Mehta, A. & Haber, J. E. (2014). Cold Spring Harb. Perspect. Biol. 6, a016428. [DOI] [PMC free article] [PubMed]
  27. Möckel, C., Lammens, K., Schele, A. & Hopfner, K.-P. (2012). Nucleic Acids Res. 40, 914–927. [DOI] [PMC free article] [PubMed]
  28. Myung, K., Chen, C. & Kolodner, R. D. (2001). Nature (London), 411, 1073–1076. [DOI] [PubMed]
  29. Myung, K., Datta, A. & Kolodner, R. D. (2001). Cell, 104, 397–408. [DOI] [PubMed]
  30. Park, Y. B., Chae, J., Kim, Y. C. & Cho, Y. (2011). Structure, 19, 1591–1602. [DOI] [PubMed]
  31. Schiller, C. B., Lammens, K., Guerini, I., Coordes, B., Feldmann, H., Schlauderer, F., Möckel, C., Schele, A., Strässer, K., Jackson, S. P. & Hopfner, K.-P. (2012). Nature Struct. Mol. Biol. 19, 693–700. [DOI] [PMC free article] [PubMed]
  32. Schiller, C. B., Seifert, F. U., Linke-Winnebeck, C. & Hopfner, K.-P. (2014). Cold Spring Harb. Perspect. Biol. 6, a017962. [DOI] [PMC free article] [PubMed]
  33. Shibata, A. et al. (2014). Mol. Cell, 53, 7–18. [DOI] [PMC free article] [PubMed]
  34. Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., Thompson, J. D. & Higgins, D. G. (2011). Mol. Syst. Biol. 7, 539. [DOI] [PMC free article] [PubMed]
  35. Sutherland, B. M., Bennett, P. V., Sidorkina, O. & Laval, J. (2000). Proc. Natl Acad. Sci. USA, 97, 103–108. [DOI] [PMC free article] [PubMed]
  36. Trujillo, K. M., Yuan, S.-S. F., Lee, E.-Y. P. & Sung, P. (1998). J. Biol. Chem. 273, 21447–21450. [DOI] [PubMed]
  37. Truong, L. N., Li, Y., Shi, L. Z., Hwang, P. Y.-H., He, J., Wang, H., Razavian, N., Berns, M. W. & Wu, X. (2013). Proc. Natl Acad. Sci. USA, 110, 7720–7725. [DOI] [PMC free article] [PubMed]
  38. Williams, R. S., Moncalian, G., Williams, J. S., Yamada, Y., Limbo, O., Shin, D. S., Groocock, L. M., Cahill, D., Hitomi, C., Guenther, G., Moiani, D., Carney, J. P., Russell, P. & Tainer, J. A. (2008). Cell, 135, 97–109. [DOI] [PMC free article] [PubMed]
  39. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
  40. Xu, Z., Zan, H., Pone, E. J., Mai, T. & Casali, P. (2012). Nature Rev. Immunol. 12, 517–531. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: Mre11 catalytic domain, 4yke

Figure S1 Elution profile of CtMre11CD and gel filtration standard (Bio-Rad) on analytical size exclusion chromatography column (S200 increase 5/150 GL). CtMre11CD (red) compared to gel filtration standard (blue): 1st peak (670 kDa), 2nd peak (158 kDa), 3rd peak (44 kDa), 4th peak (17 kDa), 5th peak (1.35 kDa). The catalytic domain of CtMre11 elutes at approximately the volume of a globular protein with a molecular weight of 158 kDa. These data show that Mre11 forms a defined multimer, given its non-globular shape presumably a dimer.. DOI: 10.1107/S2053230X15007566/no5082sup1.tif


Articles from Acta Crystallographica. Section F, Structural Biology Communications are provided here courtesy of International Union of Crystallography

RESOURCES